Alps Advisors Inc Eli Lilly & CO Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Alps Advisors Inc holds 10,368 shares of LLY stock, worth $8.26 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,368

Previous 33,321 68.88%

Holding current value

$8.26 Million

Previous $30.2 Million 69.55%

% of portfolio

0.06%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $17.7 Million - $22 Million	-22,953 Reduced 68.88%	10,368 $9.19 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $59,220 - $79,228	-100 Reduced 0.3%	33,321 $25.9 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $69,850 - $82,344	133 Added 0.4%	33,421 $19.5 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $6.73 Million - $9.27 Million	15,471 Added 86.83%	33,288 $17.9 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $153,273 - $204,944	-437 Reduced 2.39%	17,817 $8.36 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $306,281 - $359,712	-986 Reduced 5.12%	18,254 $6.27 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $320,263 - $373,171	-996 Reduced 4.92%	19,240 $7.04 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $12.3 Million - $14 Million	-41,322 Reduced 67.13%	20,236 $6.54 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $17.2 Million - $20.1 Million	61,558 New	61,558 $20 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $369,871 - $459,656	-1,576 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $3.41 Million - $4.24 Million	-15,184 Reduced 90.6%	1,576 $435,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $196,559 - $241,893	-887 Reduced 5.03%	16,760 $3.87 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $137,940 - $178,424	-764 Reduced 4.15%	17,647 $4.05 Million
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $459,767 - $595,190	-2,798 Reduced 13.19%	18,411 $3.44 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $194,254 - $257,046	-1,489 Reduced 6.56%	21,209 $3.58 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $258,370 - $298,852	-1,767 Reduced 7.22%	22,698 $3.36 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $401,893 - $483,674	2,946 Added 13.69%	24,465 $4.02 Million
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $48,810 - $60,413	410 Added 1.94%	21,519 $2.99 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $110,020 - $136,270	-1,029 Reduced 4.65%	21,109 $2.78 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $1.11 Million - $1.21 Million	-10,377 Reduced 31.91%	22,138 $2.48 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $114,667 - $133,846	1,035 Added 3.29%	32,515 $3.6 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $715,389 - $842,065	-6,427 Reduced 16.95%	31,480 $4.09 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $47.3 Million - $53 Million	-446,632 Reduced 92.18%	37,907 $4.39 Million
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $7.61 Million - $9.51 Million	-88,646 Reduced 15.47%	484,539 $52 Million
Q2 2018 Aug 02, 2018	BUY	$75.7 - $86.88 $43.4 Million - $49.8 Million	573,185 New	573,185 $48.9 Million
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $46.3 Million - $53.1 Million	-611,259 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $45.4 Million - $53.5 Million	611,259 New	611,259 $47.3 Million
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $44.8 Million - $48.1 Million	-547,248 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $42.2 Million - $46.8 Million	547,248	547,248 $46.8 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Eli Lilly & CO Transaction History